Diabetes: The World’s Largest Epidemic Unmasked

This National Diabetes Week, we are unmasking the world’s largest epidemic, Diabetes, to raise awareness about the nature of the disease and the real impact diabetes-related stigmas have on all aspects of life for people living with this disease, including their mental health and wellbeing. Diabetes is a public health problem that has reached epidemic […]

More

GBS Awarded $6.3 million Federal Government Science Grant to Manufacture Biosensor Technology

The iQ Group Global Ltd (NSX.IQG), on behalf of its portfolio company, GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant to create a pilot Biosensor manufacturing facility. […]

More

Converging Science and Business: A unique outlook on the origin of the biotech sector

Before the emergence of biotechnology, it was believed that science and business operated in their separate worlds. Throughout history, science was encased within the providence of academia, separated from the need to make a profit and satisfy shareholders. Generally speaking, scientific institutions did not focus on business enterprise and likewise business did not engage in […]

More

The Digital Revolution: The Genesis of Patient-Driven Healthcare

Digital technology is reshaping the very contours of modern healthcare with the potential to sustainably transform the industry as we know it. The broad scope of digital health, as defined by the FDA, includes categories such as health information technology, telehealth, wearable devices, telemedicine and personalised medicine.  By converging digital health and genomic technologies with […]

More

Problems with Today’s Cancer Drugs

Having the notorious status of being the ‘deadliest disease in the developed world’, cancer unscrupulously affects thousands of people across the globe each year. In 2021, it is estimated that cancer will be responsible for one in six deaths, making it the second most common cause of death globally (WHO, 2020). In Australia alone, it […]

More

Production underway on a new weapon to fight ovarian cancer

With one woman in Australia dying every eight hours from ovarian cancer, the urgency to address the unmet clinical need in cancer therapeutics has never been more paramount. A significant manufacturing agreement between OncoTEX Inc. (OncoTEX) and Sterling Pharma Solutions will see the production of novel platinum-resistant cancer-fighting drug, OxaliTEX, scaled up for preclinical and […]

More

GBS, Inc. receives approval to commence validation clinical study for rapid SARS-CoV-2 diagnostic test

NEW YORK APRIL 15, 2021 — GBS, Inc. (GBS), a life sciences company developing non-invasive, real-time point-of-care (POC) diagnostic tests, and the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Institute) have received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a validation study to test clinical samples from […]

More

The iQ Group Global celebrates 10 years of innovation

Today marks a major milestone for The iQ Group Global with its 10th anniversary. What started as a bold vision to accelerate medical innovation by CEO and founder Dr George Syrmalis in 2011, has evolved into an internationally recognised bioscience investment consortium, championing a portfolio of world-first innovations in the fields of diagnostics and oncology. […]

More